Umio

What Umio does

Umio is a UK-based private company, founded in 2014 by Chris Lawer, that operates an integrated health innovation ecosystem built around a proprietary Real Lived Experience (RLX) framework developed over two decades. The company's core product is Bergson, an AI-powered experiential intelligence platform that generates 100+ Real Lived Outcomes (RLOs) for any chronic condition, population, or geography in approximately 90 seconds, grounded in a Large Experience Model currently in patent prosecution. A sister company, Ooex Limited, provides a real-time lived experience sensing platform that captures affective moments and supports peer community and clinical engagement. The intellectual foundation is reinforced by three published books and ongoing academic affiliations, including teaching at NYIT.

Umio's revenue model is hybrid: professional services dominate, including RLX Research and Insight engagements, the RLX Outcomes Innovation Process, Education and Capability Development, and Speaking and Thought Partnership. Productized offerings include pay-as-you-go Bergson RLO generation (approximately £499 per commissioned set), Workshop Validation (£5,000), and Field Validation (~£20,000), with Enterprise Engagement and Design Direction priced on request. Go-to-market is enterprise field sales targeting medtech, pharmaceutical, and consumer health companies, supported by event-driven thought leadership, a community channel (RLX Collective, launched February 2026), and a self-serve online purchase pathway for Bergson RLO sets.

The customer base includes marquee healthcare enterprises such as Coloplast (four-year engagement credited with contributing to 7% annual organic revenue growth), Medtronic, Sanofi, Mundipharma, Lundbeck, Cochlear, Reckitt, and Systagenix, as well as government clients including the UK Office for Veterans' Affairs and ITU Scotland. The company operates from Oxford, UK, with documented project experience across 30+ countries and a primarily founder-led team that has recently expanded with the return of co-author Nicki Sutton.

Name

Umio

Legal name

Umio Limited

Website

https://umio.io

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

1–10 employees

Short description

Umio is a UK-based health innovation firm operating the Bergson AI platform and Ooex sensing platform, built on a proprietary Real Lived Experience framework, to deliver AI-generated patient insights, innovation consulting, and strategy services to medtech, pharma, consumer health, and government clients.

Ownership category

akta.pro rank

Product category

Healthcare Innovation Consulting

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (54171), Custom Computer Programming Services (541511)

SIC

Services-Management Consulting Services (8742), Services-Computer Programming Services (7371)

akta.pro primary industry

Healthcare Outcomes & Real-World Evidence (RWE) Analytics (BPAHALAN)

akta.pro secondary industries

Market Access, Pricing & Reimbursement (Evidence Generation) FSP (HLAGAOAN), Learning Experience Design (LXD) & UX for Learning (EDAGAKAF)

Keywords

• Experiential intelligence platform
• Health innovation consulting
• Lived experience research
• Medical device strategy
• AI-driven health insights

Headquarters

HQ city

Oxford

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. RLX Research and Insight Services: Custom research engagements providing Real Lived Experience research and insight for enterprises wanting to understand a condition or population before designing, innovating, or positioning. Deliverables include RLO sets, ecosystem maps, experience field reports, affective pattern analyses, and design provocations.
2. RLX Outcomes Innovation Process: End-to-end innovation methodology that frames an RLX context, identifies and prioritizes RLX outcomes, and drives strategy, design, and market growth/differentiation. Includes Bergson generation, validation workshops, field validation, enterprise engagement, and design direction services.
3. Bergson Platform Access: AI-powered experiential intelligence platform generating Real Lived Outcomes for any context. Pricing includes one-hour working session with Umio team, Bergson generation of full RLO sets, professionally formatted PDF delivery, and time to explore outcomes. Additional services include Workshop Validation (£5,000), Field Validation (est. £20,000), Enterprise Engagement (fee on request), and Design Direction.
4. Education and Capability Development: Team and organization capability building programmes including masterclasses, intensives, custom curriculum development, ongoing coaching for design and innovation teams, and live sessions using Bergson and Ooex platforms.
5. Speaking and Thought Partnership: Keynotes, provocations, fireside conversations, panels, thought leadership collaborations, editorial projects, and strategic accompaniment for organizations navigating significant transformation.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels7 records

Core offering

Umio fundamentally delivers RLX (Real Lived Experience) research, strategy consulting, and innovation-process services to health and care enterprises, supported by its proprietary Bergson AI experiential-intelligence platform and Ooex sensing platform. Its core commercial outputs are Real Lived Outcomes (RLOs) — AI-generated, lived-experience-grounded insights — packaged as platform subscriptions, paid methodology engagements, consulting projects, education, and speaking services.

Product overview

Umio operates as an integrated ecosystem of three connected platforms: Bergson (AI experiential intelligence platform), Ooex (real-time lived experience sensing platform), and Umio's service offerings (RLX Research and Insight, Strategy Consulting, Outcomes Innovation Process, Education). The core intellectual foundation is Real Lived Experience (RLX) - a proprietary framework for perceiving and designing with the hidden dynamics of life with chronic conditions. Bergson generates Real Lived Outcomes (100+ per context) in 90 seconds; Ooex provides real-time experience capture and community connection; Umio Services deliver consulting, education, and the RLX Outcomes Innovation Process. The company also publishes books (Real Lived Experience, Interactional Creation of Health, Health Ecosystem Value Design) and maintains the RLX Collective online community. All offerings share the same RLX intellectual foundation and are available individually or in combination.

Differentiator

Problem solved

Functional benefit

Brands

• Bergson: AI-powered experiential intelligence platform for generating Real Lived Outcomes, ecosystems, narratives, and design provocations for any chronic condition, population, or context worldwide.
• Ooex
• Real Lived Outcomes (RLOs)
• RLX Collective

Products and services

• Bergson AI experiential-intelligence platform that converts real lived experience data into structured Real Lived Outcomes (RLOs) for health and care organizations, including the AI-Ready RLO Set (Standard, £10,000) and Curated RLO Set (Pro, £25,000).
• Ooex Real-time lived experience sensing platform operated by Umio's sister company Ooex Limited, supporting ongoing capture of lived experience inputs that feed Bergson and Umio services.
• Umio Services Professional services umbrella covering RLX Research and Insight Services, Strategy Consulting, Education, and Speaking engagements for medtech, pharma, consumer health, health systems, and government clients.
• Real Lived Outcomes (RLOs) AI-generated insight product grounded in lived experience, sold as standardized AI-Ready RLO Sets or curated Pro RLO Sets for health and care enterprises.
• RLX Outcomes Innovation Process Proprietary methodology service that operationalizes RLX-based Real Lived Outcome generation inside a client organization's innovation process, delivered as a paid engagement.
• RLX Collective Online community platform bringing together RLX practitioners, researchers, and partners to advance lived-experience-driven health and care innovation.
• Real Lived Experience: A Radical New Design Philosophy for Health and Care (Book) Published book setting out Umio's RLX design philosophy for health and care, sold as a standalone retail product.
• Interactional Creation of Health (Book) Published book by Daniel Pesut exploring the interactional creation of health, distributed through Umio's book catalogue.
• Health Ecosystem Value Design (Book) Published book on health ecosystem value design available through Umio's book catalogue.

Quantifiable outcome

• 7% annual organic revenue growth achieved by Coloplast following inception of Umio's approach
• +3 more outcomes

Named customers13 records

Segments6 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability9 records

Feature4 records

Partnerships

Six partnerships are on record, tiered flagship, core and minor.

• UK Office for Veterans' AffairsflagshipStrategic or Co-development Partner · 1 March 2023Funded a twelve-month research and platform design project for UK Armed Forces veterans with chronic pain through the £5m Health Innovation Fund. One of 22 projects funded and one of only 2 non-university affiliated winners. Project centered on innovative dynamic model of veteran's real lived experience with chronic pain.
• Ooex LimitedcoreStrategic or Co-development PartnerOoex is Umio's sister technology company, established following the veterans chronic pain project. Ooex is the data and community layer for real-time lived experience sensing and co-composition, running on its real-time capability developed from the veterans project foundation. Umio CEO Chris Lawer also serves as CEO of Ooex. Bergson is a product of Ooex Limited, developed in partnership with Umio.
• Bergson.aicoreTechnology or IntegrationBergson is the AI platform built by Ooex Limited in partnership with Umio. It is powered by Umio's proprietary Real Lived Experience (RLX) framework - twenty years of research, philosophy, and practice. Bergson operates as the Experiential Intelligence platform for Umio's service offerings.
• OpRestoreminorStrategic or Co-development PartnerVeteran health agency engaged throughout the UK veterans chronic pain research project to ensure veteran perspectives were centered in the research design and platform development.
• OpCourageminorStrategic or Co-development PartnerVeteran health agency engaged throughout the UK veterans chronic pain research project. Contributed to research validation and platform design for veteran mental health and chronic pain support.
• New York Institute of Technology (NYIT)minorStrategic or Co-development PartnerUmio's experience model was taught to undergraduate and Masters architecture students at NYIT between 2020 and 2024, finding application in designing inclusive and equitable urban environments. Chris Lawer served as visiting fellow and adjunct lecturer.

Scale indicators7 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Strategyn: Outcome-driven innovation consultancy founded by Anthony Ulwick; Umio's CEO previously led Strategyn UK and the underlying methodology is an acknowledged ancestor of Umio's RLX outcomes approach, making Strategyn the closest methodological peer.
• frog (part of Capgemini Invent): Design and innovation consultancy with deep healthcare, medtech, and pharma work that combines experience-centred design with enterprise strategy execution - directly comparable to Umio's experience-centred innovation offering.
• IDEO: Design-led innovation firm with a long-standing health and wellbeing practice applying human-centred and experience-based methods to healthcare enterprises - a clear functional peer to Umio's RLX-led design practice.
• Lumanity: HEOR, RWE, and market access consulting firm working with pharma/biotech to generate evidence for payer decisions - closely comparable to Umio's evidence-for-market-access positioning.

Broad incumbents

• Xcenda (AmerisourceBergen): HEOR, market access, and reimbursement consulting firm serving pharma and life sciences - competes for similar market access evidence budgets and serves comparable buyer personas.
• Kantar Health (now part of Kantar): Healthcare-focused insights and analytics firm providing patient experience, market access, and outcomes research to global pharma - comparable in evidence-generation use cases though at much larger scale.
• Trinity Life Sciences: Life sciences strategy consulting firm combining commercial analytics, RWE, and primary market research to advise pharma on innovation and launch - comparable buyer set and engagement style to Umio.
• Evidera (PPD / Thermo Fisher): Large-scale HEOR, real-world evidence, and patient-centered outcomes research CRO serving pharma and medtech - overlaps with Umio's evidence-generation use cases for market access and reimbursement.
• McKinsey Health Institute: Broader strategic advisory arm serving pharma, medtech, and health systems on innovation and value-based care - competes for the same enterprise strategy wallet Umio targets.

Emerging players

• PatientsLikeMe (now part of IQVIA): Patient experience and outcomes data platform capturing lived experience across chronic conditions - directly comparable to Umio's Ooex real-time lived experience sensing layer, with greater scale but less curated methodology.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• Xtwitter.com/umiohevd
• YouTubevimeo.com/umio
• Facebookfacebook.com/umiosphere
• LinkedInlinkedin.com/company/umio
• Instagraminstagram.com/umiosphere

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Umio